Cite Filings / LYCA / 0001738048-26-000077

Feed Companies Filings Check

Sign in

SCHEDULE 13G

Statement of Beneficial Ownership

Lycia Therapeutics, Inc. Filed 2026-10-30 Acc 0001738048-26-000077

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

2026-10-30 SCHEDULE 13G Statement of Beneficial Ownership
2026-10-30 4 10% owner bought 25,004 shares at an average $25.78 ($644,711)
2026-10-28 4 10% owner acquired 7,025,307 shares (conversion)
2026-10-27 4 10% owner bought 2,045,440 shares at an average $18.41 ($37,653,863)
2026-10-26 4 Options or other derivatives
2026-10-26 4 Options or other derivatives
2026-10-26 4 Options or other derivatives

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…